In this study, we developed a support vector machine-based method to predict ion channels and their types using primary sequence information. A feature selection technique, analysis of variance (ANOVA), was introduced to remove feature redundancy and find out

an optimized feature set for improving predictive performance. Jackknife cross-validated results show that the proposed method can discriminate ion channels from non-ion channels with an overall accuracy of 86.6%, classify voltage-gated ion channels and ligand-gated ion channels with an overall accuracy of 92.6% and predict four types (potassium, sodium, calcium and anion) of voltage-gated ion channels Selleckchem E7080 with an overall accuracy of 87.8%, respectively. These results indicate that the proposed method can correctly identify ion channels and provide important instructions for drug-target discovery. The predictor can be freely downloaded from http://cobi.uestc.edu.cn/people/hlin/tools/lonchanPred/. (C) 2010 Elsevier Ltd. All rights reserved.”
“Nitric oxide, generated by the nitric oxide synthase (NOS)

enzymes, plays pivotal roles in cardiovascular homeostasis and in the pathogenesis of cardiovascular disease. The NOS cofactor, selleck chemicals tetrahydrobiopterin (BH4), is an important regulator of NOS function, since BH4 is required to maintain enzymatic coupling of L-arginine oxidation, to produce NO. Loss or oxidation of BH4 to 7,8-dihydrobiopterin (BH2) is associated with NOS uncoupling, resulting in the production of superoxide rather than NO. In addition to key roles in folate metabolism, dihydrofolate reductase (DHFR) can ‘recycle’ BH2, and thus regenerate BH4 [1,2]. It is therefore likely that net BH4 cellular bioavailability selleck reflects the balance between de nova BH4 synthesis, loss of BH4 by oxidation to BH2, and the regeneration of BH4 by DHFR. Recent studies have implicated BH4 recycling in the direct regulation of eNOS uncoupling, showing that inhibition of BH4 recycling using DHFR-specific siRNA and methotrexate treatment leads to eNOS uncoupling in endothelial

cells and the hph-1 mouse model of BH4 deficiency, even in the absence of oxidative stress. These studies indicate that not only BH4 level, but the recycling pathways regulating BH4 bioavailability represent potential therapeutic targets and will be discussed in this review. (C) 2011 Elsevier Inc. All rights reserved.”
“Regulatory T cells (Treg) have recently been identified as playing a central role in the immune response to allergens and during allergen-specific immunotherapy. We have extended our previous mathematical model describing the nonlinear dynamics of Th1-Th2 regulation by including Treg cells and their major cytokines. We hypothesize that immunotherapy mainly acts on the T cell level and that the decisive process can be regarded as a dynamical phenomenon.